ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:1902476;chloride transmembrane transport;8.0;1.0;0.875;9.628524252492122;110.5175749436453;5.311165509025885;0.0036989237740038075;0.6466132511260384;[CLDN4]
GO:0022408;negative regulation of cell-cell adhesion;6.0;0.5806842727486619;0.6134624489644754;7.765305819281922;52.92767189200162;4.7081694254602375;0.0017714415464131104;0.5638963159604501;[IFNA2, CDH1, TNR]
GO:0032570;response to progesterone;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;105.99106082751567;6.166155715036245;0.0035474254201351726;0.6384578026126634;[CLDN4]
GO:0051291;protein heterooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.113634533568402;0.00140677858073304;0.5846318204451575;[NUP62, CLDN3, NUP54, JUP]
GO:0051091;positive regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.431813958246067;277.8307104044464;4.2636448815154875;0.00929874384583087;0.650471949850128;[JUP]
GO:1902910;positive regulation of melanosome transport;7.0;1.0;0.8509193652572005;9.628524252492122;134.58136922056315;9.777073627680469;0.004504317312443425;0.8509193652572005;[CDH3]
GO:0007016;cytoskeletal anchoring at plasma membrane;6.0;1.0;0.8231203125901445;9.628524252492122;66.89368938276097;7.474488534686424;0.002238871583229107;0.7053660038532718;[JUP]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[JUP]
GO:0002159;desmosome assembly;6.0;1.0;0.8231203125901445;9.628524252492122;75.07953051527643;8.390779266560578;0.0025128443191556717;0.7522251544931926;[JUP]
GO:0050873;brown fat cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;6.444869117505266;7.282666309192915E-4;0.6198319182472036;[LAMB3]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[CLDN3]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[JUP, MMP12, ATAD2, E2F7, CCNH, HMGA1, NUP62, RAN, NUP85, GTF2H1, CDH1, RFC1, IFNA2, PRL, ARID4A, MEIS2]
GO:0006914;autophagy;4.0;0.6729672293956388;0.5864836146978194;8.39638057119949;37.75222312160081;4.39717627414001;0.001263532933085;0.4748717991491287;[ITGB4]
GO:0035635;entry of bacterium into host cell;7.0;1.0;0.8509193652572005;9.628524252492122;28.374411874040543;7.697632086000634;9.496660301113433E-4;0.7445766281117727;[CDH1]
GO:0042307;positive regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;778.7460608588023;6.063501560976162;0.02606392983099081;0.706328376990269;[CDH1, JUP]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CDH3, CDH1, CLDN3, ST14]
GO:0003382;epithelial cell morphogenesis;6.0;0.8653626801206646;0.7558016526504768;9.36615998802463;47.452274261266446;6.409777797693995;0.0015881849152503491;0.6509166472493662;[ST14, CLDN3]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CLDN3, NUP54, RAD51]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[JUP]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[JUP]
GO:0097186;amelogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;26.73958370240551;7.474488534686424;8.949498024565515E-4;0.7053660038532718;[ITGB4]
GO:0071681;cellular response to indole-3-methanol;6.0;1.0;0.8231203125901445;9.628524252492122;467.4090985487011;8.16763571524637;0.01564376188754665;0.7408135829017477;[JUP, CDH1]
GO:0071285;cellular response to lithium ion;6.0;1.0;0.8231203125901445;9.628524252492122;77.8106912628645;7.212124270218933;0.002604253811492351;0.6919486831672181;[CDH1]
GO:0007416;synapse assembly;4.0;0.8436909121759173;0.6718454560879586;9.117698628726131;35.85243951974866;5.500407508664414;0.0011999488856252476;0.5312910957882058;[CDH1]
GO:0032912;negative regulation of transforming growth factor beta2 production;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;85.63944001314535;9.083926447120524;0.002866274986747803;0.8154717862087246;[CDH3]
GO:0001954;positive regulation of cell-matrix adhesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;50.25702962731741;5.926926025970411;0.0016820575532361247;0.6262235851885184;[JUP]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[JUP, MMP12, ATAD2, E2F7, CCNH, HMGA1, NUP62, RAN, NUP85, GTF2H1, CDH3, CDH1, RFC1, IFNA2, PRL, ARID4A, MEIS2]
GO:0048333;mesodermal cell differentiation;4.0;0.8259837884571596;0.6629918942285797;8.935377071932177;21.066225782797595;7.138016298065211;7.050676185779127E-4;0.6150384854347593;[ITGB4]
GO:0070830;bicellular tight junction assembly;6.0;1.0;0.8231203125901445;9.628524252492122;56.140948375987016;6.280566066213989;0.001878987018571015;0.6443087532925187;[CLDN3]
GO:0035987;endodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;6.444869117505266;7.050676185779127E-4;0.5795909063862833;[LAMB3, LAMA3, COL8A1]
GO:0070831;basement membrane assembly;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;38.848171793302654;8.67846133901236;0.0013002133488370917;0.7669372290569613;[LAMC2]
GO:0086091;regulation of heart rate by cardiac conduction;8.0;1.0;0.875;9.628524252492122;61.172773623059015;6.193554689224359;0.002047397681241798;0.6917386748366816;[JUP]
GO:0030334;regulation of cell migration;6.0;0.4770562410916853;0.5616484331359872;7.1128459440373675;36.74126027361157;3.1319826581748256;0.0012296969163702938;0.48329005138129355;[JUP, LAMC2, LAMA3]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[CDH1, JUP]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[LAMC2]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[ITGB6]
GO:0031581;hemidesmosome assembly;6.0;1.0;0.8231203125901445;9.628524252492122;36.796901128588246;7.292166977892469;0.0012315591657128446;0.6960420709600095;[LAMB3, ITGB4, LAMA3, LAMC2]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[CLDN7, CDC6, MMP12, FGF5, CDH3, SKP2, PRL, LAMC2, MEIS2]
GO:0060901;regulation of hair cycle by canonical Wnt signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;47.7059964058805;9.777073627680469;0.001596676767095476;0.896240625180289;[CDH3]
GO:0048699;generation of neurons;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;21.75937296335754;7.474488534686424;7.282666309192915E-4;0.6724867031240476;[CDH1, CIT]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[JUP, MMP12, ATAD2, GTF2H1, E2F7, CCNH, PRL, ARID4A, HMGA1, MEIS2]
GO:0061436;establishment of skin barrier;8.0;1.0;0.875;9.628524252492122;44.874432655588755;6.781341354126479;0.0015019068766151408;0.7217981122146513;[CLDN4, STMN1, SFN]
GO:0043568;positive regulation of insulin-like growth factor receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;186.95064880168647;7.212124270218933;0.006257069970731893;0.7197477358342742;[CDH3]
GO:0048023;positive regulation of melanin biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;326.1157545976263;8.390779266560578;0.010914800821258081;0.7800242071602487;[CDH3]
GO:0010838;positive regulation of keratinocyte proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;86.61343034260064;7.57984905034425;0.0028988735665402845;0.738553198190834;[CDH3]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[CLDN3, CLDN7]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[ITGB4, ITGB6]
GO:0098911;regulation of ventricular cardiac muscle cell action potential;10.0;0.7866048967936545;0.8085434602577476;9.537552474286395;102.35229487303722;7.138016298065211;0.0034256391983155283;0.7802794972956796;[JUP]
GO:0032463;negative regulation of protein homooligomerization;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;148.87198655256626;7.379178354882098;0.004982611413824959;0.7523715242355574;[CLDN7]
GO:0043537;negative regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;356.3539069568923;6.311337724880743;0.01192684456815238;0.7380031166185408;[JUP]
GO:0007043;cell-cell junction assembly;5.0;0.7508913569872202;0.6656866903545304;8.817594036275793;53.94372379865016;5.16195311083921;0.0018054478893412883;0.554223534004606;[CDH3, CDH1, JUP, CLDN3]
GO:0038044;transforming growth factor-beta secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;9.083926447120524;0.004587596526932657;0.8797934328124444;[ITGB6]
GO:0007162;negative regulation of cell adhesion;5.0;0.5651597194614189;0.5728208715916296;7.400047131651798;38.26822196421712;4.255612709818223;0.001280802949978559;0.5078732437472537;[CDH1, TNR, CLDN7, IFNA2, ARHGAP6]
GO:0045995;regulation of embryonic development;5.0;0.5017827139744404;0.5411323688481404;6.887684228566921;27.37613670804801;4.981283082083729;9.162546586948941E-4;0.5449840603320351;[LAMA3]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[PRL, CLDN4]
GO:0051796;negative regulation of timing of catagen;8.0;1.0;0.875;9.628524252492122;253.2964854731852;9.777073627680469;0.008477605416750482;0.875;[CDH3]
GO:0050982;detection of mechanical stimulus;4.0;0.7369933605727446;0.6184966802863723;8.712233520617966;57.71052606361059;5.9928839937622085;0.0019315193712475664;0.5564763661386056;[JUP]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[CLDN7, SFN, UNG, ADAMTS20, NUP62]
GO:0032773;positive regulation of monophenol monooxygenase activity;7.0;1.0;0.8509193652572005;9.628524252492122;123.23454311126406;9.777073627680469;0.0041245492540456985;0.8509193652572005;[CDH3]
GO:0086073;bundle of His cell-Purkinje myocyte adhesion involved in cell communication;6.0;1.0;0.8231203125901445;9.628524252492122;24.262698198658363;7.9853141584524145;8.120506736983656E-4;0.7314896500084853;[JUP]
GO:2000147;positive regulation of cell motility;6.0;0.5781283279524737;0.6121844765663813;8.052987891733702;115.84051076538883;3.630744370011572;0.0038770776456263385;0.5087967485194164;[CLDN7, LAMC2]
